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E1 is the DNA replication origin recognition protein for bovine papillomavirus (BPV), and it carries out enzymatic functions
required for initiation of viral DNA replication. Cellular mechanisms likely play a role in regulating BPV DNA replication. We
are investigating the role of phosphorylation of E1 on viral replication in vivo and on E1 activity in vitro. Serine 109 is a
phosphoacceptor in vivo and is targeted by protein kinase A and protein kinase C in vitro. A viral genome carrying a serine
109 to alanine mutation replicates more efficiently than wild-type in vivo in a transient replication assay. Furthermore,
purified mutant protein, while having wild-type levels of ATPase activity, is able to bind more origin-containing DNA than
wild-type E1. Phosphorylation therefore appears to play a selective role in modulating a specific E1 function during viral
DNA replication. q 1997 Academic Press
INTRODUCTION Lambert et al., 1988). Recent work by a number of labs
has elucidated details of the mechanism of viral DNA
Papillomaviruses infect epithelial cells of a variety of
replication in vivo and in vitro (Muller et al., 1994; San-
vertebrate hosts. Their unique infectious cycle makes
tucci et al., 1990; Seo et al., 1993; Ustav et al., 1993, 1991;
them a useful model system for a variety of cellular pro- Ustav and Stenlund, 1991; Yang et al., 1991, 1991a, 1993).
cesses, including DNA replication. The bovine papillo- Replication of papillomavirus DNA in virally transformed
mavirus type-1 (BPV) genome is a double-stranded circu- or transiently transfected cells requires three viral com-
lar DNA molecule, 7946 base pairs (bp) in length. In ponents: a cis-acting origin sequence and two viral pro-
infected cells, this DNA is complexed with cellular his- teins, E1 and E2 (Ustav et al., 1993, 1991; Ustav and
tones to form a viral ‘‘mini-chromosome.’’ Stenlund, 1991; Winokur and McBride, 1992). The mini-
The natural course of papillomavirus infection requires mum functional viral replication origin contains binding
entry of infectious virions into the basal cells of the epi- sites for both E1 and E2 proteins, as well as an A/T-rich
thelium, establishing a latent infection (Shah and Howley, domain. The E2 transactivator and its repressor deriva-
1990). In the basal cells, the viral DNA is maintained as tives are responsible for regulating viral transcription.
an extrachromosomal episome, expressing viral genes E2 also forms a complex with E1; its role in viral DNA
required for the maintenance of the viral DNA in the replication is believed to be one of enhancing the recruit-
undifferentiated cell. As basal cells divide, some of the ment and binding of E1 to its target site in the replication
daughter cells migrate toward the surface of the epithe- origin (Lusky et al., 1993; Mohr et al., 1990; Yang et al.,
lium, following a differentiation pathway. Only in the su- 1991). One model for initiation of viral DNA replication
prabasal granular layer is the viral genome amplified to requires the assembly of E1 at the origin, followed by
high copy number, coordinated with expression of genes distortion of the DNA at the A/T rich sequence. E1 heli-
required for assembly of new infectious virions (Howley, case activity then initiates unwinding of the DNA. Cellular
1990; Stoler et al., 1992). replication proteins are recruited to the replication origin,
In latently infected basal cells and in tissue culture, forming an active replication fork complex. This model
the viral genome is maintained at a relatively constant is consistent with known functions of the E1 protein (Gil-
copy number of 50 to 200 copies per cell. This mainte- lette et al., 1994; MacPherson et al., 1994; Park et al.,
nance is accomplished by replicating the resident viral 1994; Seo et al., 1993; Yang et al., 1993).
genomes an average of once per cell cycle. Viral DNA In vitro, BPV DNA replication can occur in the absence
replication occurs in the S phase of the cell cycle in of E2, however E2 greatly stimulates replication activity,
synchrony with cellular DNA (Gilbert and Cohen, 1987; especially at low E1 concentrations (Bonne-Andrea et
al., 1995; Yang et al., 1991, 1991a). It has recently been
demonstrated that E1 can efficiently drive multiple1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 409-845-9274. E-mail: mlentz@bioch.tamu.edu. rounds of DNA synthesis from a single template in vitro
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(Bonne-Andrea et al., 1995). This suggests important con- tide used was 5*GACGGAAAGAAGGAGCAAAGCG3 *.
This oligonucleotide hybridizes to the opposite strand totrol mechanisms are active in the cell to maintain the tight
control on copy number observed in latently transformed the one above; the underlined GAA encodes glutamic
acid and replaces the alanine codon generated in thecells that are not observed in vitro.
E1 is phosphorylated at numerous sites that are not mutant above.
Full-length wild-type and the two mutant fE1 were sub-completely defined (Lentz et al., 1993). Phosphorylation
is a common mechanism for activating and inactivating cloned into the BamHI site of the baculovirus transfer
vector pVL1393 (Pharmingen). The mutations were alsoprotein function. Kinases and phosphatases regulate
many aspects of the cell cycle, including DNA replication. incorporated into the full-length BPV genome by replac-
ing the wild-type XmaI to EcoRI fragment of the plasmidWe are analyzing the role of phosphorylation of E1 on
its DNA replication activities. Here we identify serine 109 pMLBPV (Lusky and Botchan, 1984), with the correspond-
ing fragment from the mutant pGEMfE1 plasmids. Sub-as a target for phosphate addition in vivo and in vitro.
Viral genomes carrying a serine to alanine mutation at cloning was by established procedures (Maniatis et al.,
1982).position 109 of E1 replicate more efficiently than the wild-
type genome in a transient replication assay. In vitro DNA
Cells and virusesbinding activity of purified E1 is also modified by this
mutation. When serine 109 is mutated to glutamic acid,
Mouse C127 cells were grown and maintained in Dul-
replication activity is reduced compared to wild-type. The
becco’s modified Eagle’s medium (Gibco) supplemented
implications for phosphorylation of E1 on BPV replication
with 10% fetal bovine serum (JRH Biosciences), penicillin,
are discussed.
and streptomycin. Chinese hamster ovary (CHO) cells
were cultured in F-12 medium supplemented with 10%
MATERIALS AND METHODS
fetal bovine serum, penicillin, and streptomycin. Culture
of Spodoptera frugiperda Sf9 cells and their infection byDNA manipulations
recombinant baculoviruses was as previously described
The full-length E1 gene from BPV-1 was cloned by
(Mohr et al., 1990; Summers and Smith, 1987). Generation
polymerase chain reaction (PCR) as described (Innis and
of recombinant baculovirus expressing either wild-type
Gelfand, 1990), using VENT Polymerase (New England
or alanine mutant BPV E1 protein utilized the Pharmingen
Biolabs) according to manufacturer’s recommended
Baculogold viral DNA in a lipofection protocol (Lipofectin,
modifications. Primers used were 5*f-E1 (5*GCTCTA-
Gibco BRL). Sf9 cells (3 1 106) were plated onto 60-
GAGGATCCATGGACTACAAGGACGACGATGACAAGAT-
mm dishes in Grace’s medium with no supplements and
GGCAAACGATAAAGGTAGC3 *) for the 5* end of E1 and
allowed to adhere for 1 hr. A mixture of 0.2 mg Baculogold
3 *-E1 (5*CCGGATCCGTCGACTCAATCAACTGCATTTGT-
DNA, 1.7 mg recombinant DNA, and 40 ml medium was
GTTTCTTGCGC3 *) for the 3 * end of E1. Both ends of the
added to 10 ml of Lipofectin in 25 ml of medium and
PCR product can be digested by BamHI. The sequence
incubated 15 min at room temperature. Medium was
5*f-E1 incorporates nucleotides coding for methionine
added to 1 ml, then added to cells, followed by incubation
followed by the eight-amino-acid peptide recognized by
for 12 hr at 277, rocking the plates occasionally. The DNA-
the anti-FLAG M2 monoclonal antibody (IBI) prior to the
containing medium on the cells was replaced by 3 ml
amino-terminal methionine of native E1. The full-length
complete medium, and cells were incubated 4–5 days.
E1 gene with the 5* FLAG coding sequence (f-E1) was
Recombinant viruses were plaque purified (Summers
cloned at the BamHI site of the phagemid vector
and Smith, 1987).
pGEM3Zf(0) (Promega) to generate pGEMfE1. The
cloned E1 gene was completely sequenced using the In vivo replication
Sequenase Kit (USB) and found to be identical to the
published sequence (Chen et al., 1982; Sanger et al., Analysis of transient replication of BPV DNA in mouse
C127 cells was as described (Lentz et al., 1993) with the1977, with corrections as published in Meyers et al.,
1995). following modifications. Full-length wild-type or mutant
BPV genomes were removed from the pML plasmidMutant E1 genes were generated by oligonucleotide-
directed mutagenesis using the protocol of Deng and background by digestion with BamHI. Digestion was ana-
lyzed by agarose gel electrophoresis to confirm thatNickoloff (1992). pGEMfE1 was used as the template.
The oligonucleotide generating a serine to alanine muta- equivalent amounts of DNA were present in each sam-
ple. Replicated BPV DNA was isolated by modified HIRTtion at amino acid position 109 was 5*CGCTTTGCTCCT-
GCTTTCCG3 *. On the opposite strand, the underlined extraction on Days 2–6 following electroporation (Hirt,
1967). After all samples were collected, the isopropanol-‘‘C’’ converts the TCA serine codon to a GCA alanine
codon. Subsequently, the alanine mutant-containing precipitated DNA was collected by centrifugation,
washed with 70% ethanol, and air-dried. DNA was dis-plasmid was used as a template to convert position 109
to a glutamic acid by the same method. The oligonucleo- solved in 10 ml water containing 20 mg/ml RNase A and
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incubated at 657 for 20 min. After cooling, 15 ml of restric- continued for 3–4 hr. Labeled E1 was purified as de-
scribed above.tion enzyme mix was added and the samples were incu-
bated at 377 12–16 hr. Restriction enzyme mixes con-
Western blottained manufacturer-supplied buffer, DpnI, and HindIII
or EcoRI restriction enzymes. Digestion products were
Western blot analysis of E1 protein was performed as
separated on 0.8% agarose gels, covalently bound to
described (Harlow and Lane, 1988). Anti-FLAG mono-
nylon membrane by capillary transfer and UV treatment,
clonal antibody M2 (IBI) was used to detect E1 proteins
and probed with a radiolabeled BPV-specific probe. The
tagged at their amino terminus with the FLAG peptide.
probe was generated by random-primed synthesis using
the ‘‘Prime-a-Gene’’ Labeling System (Promega) ac- Phosphopeptide analysis
cording to manufacturer’s directions, using linear BPV
Tryptic digestion and two-dimensional analysis ofgenome as a template. Blots were washed, dried, and
phosphopeptides was performed essentially as de-exposed to X-ray film (Amersham). As a control, blots
scribed (Boyle et al., 1991). Purified E1 proteins werewere stripped by washing in boiling 0.5% sodium dodecyl
precipitated with 10% trichloroacetic acid and washedsulfate and then reprobed with a random-primed frag-
with ice-cold acetone. The proteins were oxidized in per-ment of pIL7 containing the rat cytochrome oxidase II
formic acid, lyophilized, and then treated overnight withgene (Glaichenhaus and Cuzin, 1987). Quantitation was
10 mg TPCK (tosylsulfonylphenylalanyl chloromethyl ke-performed on a Fuji BAS 2000 phosphorimager system.
tone)–trypsin in 0.05 M ammonium bicarbonate, pH 8.3.As a control, replication was also analyzed utilizing E1
The digested proteins were washed several times withand E2 expressed from heterologous promoters and a
deionized water and lyophilized to dryness. PeptidesBPV-origin containing plasmid in CHO cells as described
were separated on cellulose thin-layer plates (Whatman)(Chiang et al., 1992b; Holt and Wilson, 1995). E2 was
by electrophoresis in the first dimension in pH 1.9 bufferexpressed from the adenovirus major late promoter from
(1794:156:50; deionized water:glacial acetic acid:formicplasmid pCG-E2 (a gift from V. Wilson); wild-type and
acid) for 30 min at 1000 V. After the plates were dried,mutant fE1 were expressed from the SV40 early promoter
peptides were separated in the second dimensionfrom plasmid pSG5 (a gift of S. Khan). The target plasmid
by chromatography in phosphochromatography bufferwas pGEM (Promega) containing a 106-bp AluI fragment
(94:75:63:19; n-butanol:deionized water:pyridine:glacialspanning nucleotides 7892 to 51 of the BPV genome.
acetic acid). Plates were dried and exposed to X-ray film.One microgram of the target plasmid and 5 mg of each
expression plasmid were used in each experiment.
In vitro phosphorylation of E1
Expression and purification of E1 Purified fE1 proteins were phosphorylated with pro-
tein kinase A (PKA, Promega) in a 15-ml reaction con-
One hundred- to 200-ml suspension cultures of Sf9
taining 40 mM Tris – HCl, pH 7.4, 20 mM MgCl2 , 0.2cells were infected as described (Mohr et al., 1990). At
mM ATP, 2.5 mCi [g32P]ATP, 20 – 25 U PKA, and 150 ng
48 hr p.i., cells were recovered by centrifugation at 1000
E1. E1 was similarly phosphorylated by protein kinase
g for 5 min, rinsed with phosphate-buffered saline (PBS,
C (PKC, Promega) in reactions containing 20 mM
Maniatis et al., 1982), and repelleted. Cell pellets were
HEPES, pH 7.4, 1 mM DTT, 10 mM MgCl2 , 200 mg/mlused directly or stored at 0707. Purification of E1 from
phosphatidyl serine, 1 mM CaCl2 , 0.1 mM ATP, 2.5salt-washed nuclei was as previously described (Mohr
mCi [g32P]ATP, 5 – 10 ng PKC, and 150 ng E1 protein.
et al., 1990). An immunoaffinity column was prepared
Reaction products were analyzed by separation on 10%
with 1–2 ml of FLAG M2 monoclonal antibody complexed
denaturing polyacrylamide gels, transfer to nitrocellu-
to Sepharose (IBI) and used according to manufacturer’s
lose, and autoradiography.
instructions. Bound E1 was eluted with 0.1 M glycine –
HCl, pH 3.0, or synthetic FLAG peptide (IBI). Fractions of ATPase assay
acid eluted E1 were neutralized with 0.05 M Tris–HCl,
pH 8.0, and then analyzed by polyacrylamide gel electro- Purified fE1 (30–150 ng) was added to a reaction mix
in a total reaction volume of 20 ml containing 50 mMphoresis. E1-containing fractions were pooled, concen-
trated by dialysis against solid sucrose, dialyzed into Tris–HCl, pH 7.5, 5 mM MgCl2 , 1 mg BSA, 1 mg denatured
salmon sperm DNA, and 5 mCi [g32P]ATP. Reactionsstorage buffer (50 mM Tris–HCl, pH 7.8, 1 mM EDTA, 1
mM dithiothreitol (DTT), 12.5 mM MgCl2 , 100 mM KCl, were incubated at 307 for 10–120 min. One microliter of
reaction was spotted onto a cellulose PEI plate (J. T.0.3 M NaCl, 10% glycerol), aliquoted, and stored at 0707.
For in vivo 32P-labeled proteins, cells were incubated for Baker Inc.) and air-dried. Plates were developed in 0.75
M KH2PO4 pH 3.5, air-dried, and exposed to X-ray film.1 hr in phosphate- and serum-free Grace’s medium at
approximately 45 hr p.i. at 107 cells/ml. Then 100 mCi/ Reactions were quantitated on a phosphorimager.
Alternatively, fE1 was immunoprecipitated from crudeml of [32P]orthophosphate was added, and incubation
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TABLE 1nuclear salt-wash extracts using FLAG M2 monoclonal
antibody and protein A–Sepharose beads, as described Consensus Protein Kinase A and Protein Kinase C Sites in
below. After the beads were washed, ATPase reactions Papillomavirus E1 Proteins
were performed as above directly with immune com-
plexed fE1.
Origin binding
A modified immunoprecipitation procedure was used
(Wilson and Ludes-Meyers, 1991). Purified or crude E1
was prepared as described above. Sf9 cells infected with
recombinant baculovirus expressing BPV L1 protein were
used as a control for nonspecific binding of cellular or
baculovirus proteins during immunoprecipitation. Radio-
labeled origin-containing (ori/) or origin-lacking (ori0)
DNA probes were generated by PCR, using primers la-
beled at their 5* ends by reaction with T4 polynucleotide
kinase (Promega) and [g32P]ATP (Maniatis et al., 1982).
fE1 or fL1 protein was precipitated from solution by bind-
ing to FLAG M2 monoclonal antibody followed by binding
to protein A–Sepharose beads (Sigma). Immune com-
plexes were washed with 20 mM Tris–HCl, pH 8.0, 5 a Kennelly and Krebs (1991).
mM KCl, 1 mM MgCl2 , 1 mM DTT, and 0.3 M NaCl, and b Meyers et al. (1995).
then resuspended in 20 ml binding buffer containing 30 c HPV-5, -8, -12, -19, -20, -21, -25, -48, -50, -65 (Meyers et al., 1995).
mM HEPES, pH 7.4, 7 mM MgCl2 , 2 mg poly[d(I-C)], 20
mM potassium glutamate, and 1000 cpm each of ori/
(200 bp) and ori0 (80 bp) DNA fragments. Reactions were (Lentz et al., 1993). Other in vivo phosphates appear to
incubated at 307C, for 30 min. Unbound probe was be on serine residues; however, specific sites of serine
washed from the immune complexes, which were then phosphorylation have not been identified. By sequence
treated with 70 ml dissociation buffer (1% SDS, 50 mM homology to known target sequences (Kemp and Pear-
EDTA, pH 8.0), for 15 min at 657. Bound DNA was purified son, 1990; Kennelly and Krebs, 1991), we identified serine
by phenol/chloroform extraction and ethanol precipita- 109 as a putative site for phosphorylation by cAMP-de-
tion, followed by separation on 5% polyacrylamide gels pendent protein kinase (PKA), as well as protein kinase
in 11 TBE buffer (Maniatis et al., 1982). The gels were C (PKC) (Table 1). A serine is present at a similar position
dried and exposed to X-ray film and then quantitated on and context in many, but not all papillomavirus E1 pro-
a phosphorimager. Immunoprecipitations were done in teins (Table 1).
duplicate, with one sample used for a control Western To determine whether serine 109 can be a target for
blot, described above. phosphate addition on E1, we mutated the TCA codon
of serine 109 to GCA, coding for alanine, which lacks the
RESULTS phosphoacceptor hydroxyl group (E1S109A). The mutant
E1 gene was used to generate a recombinant baculovi-E1, the major replication protein of the papillomavi-
rus for synthesis and purification of mutant E1 protein.ruses, is capable of driving multiple rounds of DNA syn-
Both wild-type and mutant E1 proteins were expressedthesis from a given template molecule in vitro (Bonne-
and purified from insect cells infected with recombinantAndrea et al., 1995). Replication of BPV DNA in latently
baculoviruses. Wild-type or mutant E1 protein (150 ng)infected cells, however, is tightly regulated through the
was phosphorylated in vitro using purified kinases. Reac-cell cycle. The activity of the E1 protein is therefore likely
tion products were analyzed by SDS–polyacrylamide gelto be modulated by cellular mechanisms during the
electrophoresis, followed by transfer to a nitrocellulosecourse of a natural infection or during replication in tis-
membrane and autoradiography. As can be seen in Fig.sue culture cells. E1 is known to be phosphorylated in
1A, E1 is efficiently labeled by PKA and PKC, while thevivo and in vitro (Lentz et al., 1993); no other protein
S109A E1 protein is utilized as a substrate less efficientlymodifications have been identified. We hypothesized that
by both kinases. Autophosphorylation by both kinasesphosphorylation of E1 may play a role in regulating BPV
was also observed, as well as efficient labeling of anDNA replication in living cells.
unidentified component of the PKC reaction. The E1
E1 serine 109 is a phosphate acceptor site amino acid substitution resulted in a 70% reduction in
counts incorporated by PKA, while PKC labeling was re-Previous work indicated that threonine 102 is a site
for phosphate addition by the cdk28/cdc2 p34 kinase duced by 40%. Sequence analysis of the E1 protein re-
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serine 109 as a phosphoacceptor on the E1 protein both
in vivo and in vitro.
In vivo replication of wild-type and mutant BPV
genomes
Having determined the potential of serine 109 as a
phosphoacceptor site, we analyzed the effect of a serine
109 to alanine mutation on replication of BPV DNA in
vivo. A transient replication assay was used, measuring
the accumulation of BPV DNA in cultured cells as the
cells divide. The copy number of BPV genomes per cell
is maintained at a relatively constant level by controlled
replication of the BPV genomes during the S phase of
the cell cycle. As cell density increases over time, the
signal from BPV DNA increases proportionally in this
assay.
Transient replication of wild-type BPV and BPV
E1S109A is shown in Fig. 3A for a representative experi-
ment. The mutant BPV genome consistently replicates toFIG. 1. In vitro phosphorylation of E1 proteins. Wild-type and S109A
E1 proteins purified from recombinant baculovirus-infected Sf9 cells higher levels than the wild-type genome. The blots were
were incubated with protein kinase A (PKA) or protein kinase C (PKC) in stripped and reprobed with a cytochrome oxidase II gene
the presence of [g-32P]ATP, as described under Materials and Methods. probe. Results from this cellular mitochondrial gene dem-
Reactions products were separated on 10% SDS–polyacrylamide gels,
onstrated that recovery of low-molecular-weight DNAtransferred to nitrocellulose, and autoradiographed. (A) Autoradiograph
from the different samples was consistent (data notof reaction products. The positions of E1 and autophosphorylated PKA
and PKC are indicated. The sizes of molecular weight standards in shown). The in vivo replication results are quantitated in
kilodaltons are indicated on the left. (B) Western blot analysis of E1 Fig. 3B. BPV E1S109A DNA levels are reproducibly two-
proteins from the reaction products shown in part A. The region of the to threefold higher than those of wild-type. This result
blot containing E1 is shown.
was consistent over five independent replication experi-
ments using different DNA preparations.
While we have shown that serine 109 is a target inveals several other putative target sites for both PKA and
vivo and in vitro for phosphate addition, it is possible thatPKC. Phosphorylation of one or more of these positions
the replication phenotype of the mutant is the result ofcould account for the residual labeling of the S109A mu-
a more general effect on the local structure of the E1tant by these kinases in vitro. The membrane was probed
protein. To test whether the observed increase in replica-with monoclonal antibody to the amino terminal tag on
tion resulted from lack of phosphate addition, a serinethe E1 proteins. The Western blot, shown in Fig. 1B,
109 to glutamic acid mutation was created in the E1illustrates that equivalent amounts of E1 were present in
each reaction. These results demonstrate that E1 serine
109 is a target site for PKA and PKC in vitro.
Wild-type and mutant E1 proteins were labeled in vivo
with [32P]orthophosphate and purified. Two-dimensional
analysis of tryptic phosphopeptides revealed that wild-
type E1 contains a major phosphopeptide only weakly
utilized in the E1S109A mutant (Fig. 2). There were no
other major differences in the phosphopeptide map be-
tween the wild-type and mutant E1 proteins. These ex-
periments were done by infecting insect Sf9 cells with
recombinant baculoviruses expressing the wild-type or
mutant E1 proteins. While we were able to demonstrate
a difference in the tryptic phosphopeptide map, it must
FIG. 2. In vivo phosphorylation of wild-type and mutant E1 proteins.be noted that this reflects invertebrate cell modification
Sf9 cells were infected with recombinant baculoviruses expressingof E1. Detailed studies on simian virus 40 large T antigen
either wild-type fE1 or fE1 S109A. Late in infection, cells were labeledhave demonstrated qualitatively similar phosphorylation
with [32P]orthophosphate and E1 proteins were purified. The E1 proteins
between insect and mammalian cells, while there can were subjected to tryptic digestion followed by two-dimensional sepa-
be notable differences in quantitative phosphate addition ration of tryptic peptides. Wild-type E1 contains a major labeled peptide
not present in the E1S109A sample (arrows).(Ho¨ss et al., 1990). Taken together, our results identify
AID VY 8375 / 6a28$$$283 01-15-97 13:46:37 vira AP: Virology
6 ZANARDI ET AL.
FIG. 3. In vivo replication of BPV DNA. Wild-type and mutant viral genomes were introduced into mouse C127 cells by electroporation. Low-
molecular-weight DNA samples were harvested on Days 3–6 postelectroporation (p.e.) and then examined by Southern blot analysis. (A) Replication
of BPV DNA in C127 cells. Blots were probed with random-primed BPV genomic DNA. M, marker lane containing 200 pg of purified linear BPV
DNA. (B) Southern blots were quantitated on a phosphorimager. Arbitrary units of signal intensity are plotted against time postelectroporation.
Hatched bars, BPV with wild-type E1; solid bars, BPV with E1 S109A mutation.
gene, and this mutant was subcloned into the BPV ge- rect effect on replication functions of E1. To test this
possibility, replication assays were performed in CHOnome. The negative charge at physiological pH of the
glutamic acid side chain may mimic a constitutively phos- cells using E1 and E2 expressed from heterologous pro-
moters, along with a target plasmid containing the BPV-phorylated serine side chain. In a transient replication
assay, this mutant replicated less efficiently than ge- 1 origin. In this system, E1 and E2 proteins and the repli-
cation origin sequences are the only BPV componentsnomes carrying the wild-type E1 gene (Fig. 4). In the
experiment shown, the mutant replicated to a level of present, eliminating indirect effects on other viral genes.
In several repetitions of this assay, inconsistent results70% of that of wild-type. This result supports our conclu-
sion that the replication phenotype observed is directly were obtained. In one experiment, there was no observ-
able replication difference between wild-type and S109Arelated to phosphorylation of serine 109. Loss of the abil-
ity to add phosphate to serine 109 results in higher rates mutant E1. In other experiments, the mutant replicated
several percent to 1.5-fold better than wild-type (data notof DNA replication, while a constitutive negative charge
at this position reduces replication. Phosphorylation of shown).
BPV efficiently transforms rodent cells. This phenotypeE1 at serine 109 may therefore be involved in downregu-
lating E1 activity in cycling cells. is primarily due to activity of the products of the E5, E6,
and E7 genes (Howley, 1990). There has been someE1 has been shown to modulate E2-mediated trans-
activation of the BPV-1 P89 promoter, responsible for ex- controversy over whether mutations in the E1 gene affect
the transformation efficiency of BPV. Reexamination ofpression of the E6 and E7 transforming genes (Le Moal
et al., 1994; Sandler et al., 1993; Vande Pol et al., 1995). E1 mutants from several labs indicates that E1 mutations
Therefore, it is possible that the replication phenotype generally result in lower transformation efficiency
observed for the S109A mutant E1 is an indirect effect (Chiang et al., 1992a). This phenotype is hypothesized to
resulting from transcription modulation rather than a di- result from loss of viral DNA due to replication defects.
The S109A BPV genome transforms cells to the same
level as wild-type, as shown in Table 2. Since mutant
viral DNA replication is higher than that of wild-type,
it is not surprising that transformation efficiency is not
significantly reduced. This result also suggests that the
TABLE 2
Focus Formation
FIG. 4. In vivo replication of wild-type and E1 S109E mutant genomes.
Wild-type and mutant viral genomes were introduced into mouse C127 Experiment No. Wild-type E1 S109A
cells by electroporation. Low-molecular-weight DNA samples were har-
vested on Days 2, 4, and 6 postelectroporation (p.e.) and then examined 1 280 264
by Southern blot analysis. Blots were probed with random-primed BPV 2 292 296
genomic DNA. M, marker lane containing 200 pg of purified linear BPV 3 168 147
DNA.
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increased level of DNA replication observed for the mu-
tant genome is not the result of differences in electropor-
ation efficiency.
ATPase activity of wild-type and mutant proteins
We next wished to determine the activity or activities
of the mutant E1 protein that was responsible for the
replication phenotype. We examined purified wild-type
and mutant E1 proteins for several specific E1 activities
in vitro.
E1 is a DNA-dependent ATPase (MacPherson et al.,
1994). The hydrolysis of ATP likely provides a source of
energy for enzymatic unwinding of template DNA by E1
helicase activity. Wild-type or mutant E1 proteins were
immunoprecipitated from nuclear extracts, washed, and
analyzed for their ability to hydrolyze [g32P]ATP to free
phosphate. ATP hydrolysis was analyzed by chromatog-
raphy of reaction products and quantitated on a phos-
phorimager. In several independent experiments using
different protein preparations, there was no major differ-
ence in the ATPase activity of the mutant E1 protein
compared to wild-type (data not shown). These experi-
ments were done using a range of E1 concentrations
and reaction times. Alteration of ATPase enzyme activity
FIG. 5. Binding of E1 to the viral replication origin. Wild-type (wt) and
by the serine to alanine substitution cannot account for S109A E1 proteins were immunoprecipitated from crude extracts of
the increased replication observed for the E1 mutant. recombinant baculovirus-infected Sf9 cells. BPV L1 protein (L1) ex-
pressing cells were used as a negative control. (A) Immunoprecipitates
were incubated with 32P-labeled DNA fragments, followed by removalReplication origin binding activity
of unbound DNA. Bound DNA was purified and separated on 5% poly-
acrylamide gels which were dried and exposed to X-ray film. ori/, 200-We next analyzed the ability of wild-type and mutant
bp DNA fragment containing the BPV replication origin; ori0, 80-bpE1 proteins to interact with origin-containing DNA frag-
fragment without BPV replication origin sequences. (B) Western blot ofments in a sequence-specific manner. Binding of E1 to
an identical immunoprecipitate reaction using monoclonal antibody to
the replication origin is the first requisite step in initiating the amino-terminal tag on the E1 proteins. Purified E1 (pur. E1) was
viral DNA replication. E1 recognizes and binds to a con- used as a positive control. The positions of E1 and the heavy (H) and
light (L) chains of the immunoprecipitating antibody are shown.served 18-bp inverted repeat at or near the site where
template melting and DNA synthesis are initiated (Holt
et al., 1994). Recognition and binding to this origin se-
or ori0 DNA. The immunoprecipitation reactions werequence are intrinsic properties of the E1 protein, although
performed in triplicate, with two sets run directly on dena-in vivo E1 binding to the origin is believed to be facilitated
turing polyacrylamide gels for analysis of E1 proteins.by interaction with the viral E2 protein and an adjacent
Both Coomassie staining (not shown) and Western blot-E2 binding site (Lusky et al., 1993; Mohr et al., 1990;
ting (Fig. 5B) demonstrate that there are no major differ-Yang et al., 1991).
ences in the amount of E1 present in each DNA bindingWild-type and mutant E1 proteins were immunoprecipi-
reaction. This suggests that differences in DNA bindingtated from Sf9 cell nuclear extracts. Immune complexes
between the two proteins cannot be accounted for bywere washed and then incubated with radiolabeled ori/
differences in expression, antibody binding, or proteinand ori0 DNA fragments. The immune complexes were
stability through the purification protocol. In the experi-again washed to remove unbound DNA fragments, fol-
ment shown, there may be more wild-type E1 protein thanlowed by extraction of bound DNA from the immune com-
mutant, making the differences in DNA binding efficiencyplexes. The recovered DNA was analyzed by polyacryl-
even more striking.amide gel electrophoresis, and the results are shown in
DNA binding activity of the two E1 proteins was quanti-Fig. 5A. E1 with the serine to alanine substitution was
tated on a phosphorimager. In five independent experi-consistently able to bind more DNA than wild-type E1.
ments, S109A was found to bind from 1.6- to greater thanWild-type E1 bound almost exclusively ori/ DNA, while
8-fold more ori/ DNA than wild-type. Interestingly, thisthe S109A mutant E1 bound both ori/ and significant
ratio equals or exceeds the differences observed in repli-amounts of ori0 DNA. Extracts from cells expressing BPV
L1 protein as a negative control did not bind either ori/ cation efficiency in mouse C127 cells. Therefore, the in-
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creased binding efficiency of the mutant E1 protein could could recognize this site as a target. We have shown
that in vitro, both PKA and PKC utilize serine 109 as aaccount for the replication phenotype of the mutant.
target. Furthermore, a mutation in which the wild-type
serine in converted to glutamic acid has a reduced repli-DISCUSSION
cation phenotype compared to the wild-type protein.
Whereas alanine prevents phosphate addition by remov-Papillomaviruses provide an attractive model system
for analyzing control of DNA replication in eukaryotic ing the phosphoacceptor hydroxyl group, glutamic acid
has a negative charge that may mimic a constitutivelycells. During a latent period in the course of a natural
infection, viral DNA is maintained as an episome at a phosphorylated serine. The striking difference in the phe-
notypes of the two mutants lends support to our conclu-constant copy number. This mode of viral DNA replica-
tion is mimicked in cells grown transiently in monolayer sion that the presence or absence of phosphate at posi-
tion 109 is directly responsible for the replication pheno-culture in the laboratory, as well as in stably transformed
cell lines. This is in contrast to most viruses in permissive type of the viral genomes.
It is unlikely that there are major changes in the overallcells which undergo a lytic pathway, including uncon-
trolled replication to high copy number. High-copy ampli- structure of the mutant E1 protein, since another intrinsic
activity of the protein, enzymatic hydrolysis of ATP, isfication of papillomavirus DNA is restricted to terminally
differentiated keratinocytes, where changes in DNA repli- unaffected. Furthermore, the quantities of mutant E1 pro-
tein purified from crude nuclear extracts match that ofcation and gene expression result in assembly of infec-
tious progeny virions. Undifferentiated cells may contain wild-type, suggesting that there are no major differences
in the overall stability of the protein. The promoters fora factor(s) that actively restricts viral DNA replication to
low-copy-number maintenance or may be missing a fac- expression of E1 and other BPV proteins in the viral ge-
nome are weak. We are unable to detect E1 in transientlytor(s) required for vegetative DNA amplification.
We are investigating the hypothesis that kinases and/ transfected cells. We cannot rule out the possibility that
expression of the mutant E1 protein from the BPV ge-or phosphatases play an important role in regulating pap-
illomavirus DNA replication by altering the phosphate nome is altered in some way that would account for the
observed replication phenotype. While it is not likely, wecontent of viral replication proteins. There are well-char-
acterized structural and functional similarities between cannot formally rule out the possibility that the replication
defects we have observed are not an indirect result ofpapillomavirus E1 proteins and the large tumor (T) anti-
gen of simian virus 40 (SV40). SV40 large T antigen is affecting the transcriptional regulatory properties of E1.
Our experiments to analyze replication function in theregulated both positively and negatively by phosphoryla-
tion. Enzymatic removal of phosphate from serine resi- absence of viral genes other than E1 and E2 were incon-
clusive.dues or mutation of phosphoacceptor serines of large T
antigen increases site-specific DNA binding activity and We do not believe the presence of the FLAG sequence
at the amino terminus of the purified E1 proteins inter-enhances DNA replication in vivo and in vitro (Fanning,
1992, and references therein). On the other hand, phos- feres with the interpretation of our experimental results.
BPV-1 E1 with a nine-amino-acid tag (EE) efficiently repli-phorylation of threonine 124 is required for efficient DNA
binding by large T antigen and initiation of DNA replica- cates origin-containing DNA in vitro (Yang et al., 1991). A
direct comparison of untagged and FLAG-tagged humantion. It has been also demonstrated that mutation of
phosphorylation sites in the BPV E2 protein, which plays papillomavirus type 11 (HPV-11) E1 in an in vivo transient
replication assay demonstrated that there were no func-an auxiliary role in viral DNA replication, increases DNA
replication and stable copy number (McBride and How- tional differences between the two proteins (Grodberg et
al., personal communication).ley, 1991). Since E1 plays a more direct role in replication,
we have begun analyzing the activity of E1 phosphoryla- We have shown that the mutant E1 protein has in-
creased affinity for the replication origin in DNA bindingtion site mutants. We have demonstrated that alanine
substitution of an E1 phosphate acceptor site at serine assays. Several groups have mapped the DNA binding
domain of E1 using deletion mutagenesis and found this109 alters the replication phenotype of the virus in tran-
sient replication assays, resulting in an increase in viral activity to reside in amino-terminal half of the protein.
The amino-terminal boundary of the DNA binding domainDNA replication. Furthermore, the effect on DNA replica-
tion can be accounted for by an increase in the ability maps between residues 122 and 162 (Sarafi and
McBride, 1995; Thorner et al., 1993; Leng and Wilson,of the mutant E1 protein to bind to the replication origin
on the viral DNA. unpublished results). Serine 109 falls outside of this func-
tional domain. Our DNA binding assays are carried outSeveral lines of evidence support the hypothesis that
loss of phosphorylation is responsible for the replication in the absence of the E2 protein, so modified interaction
with E2 cannot account for our in vitro observations.phenotype of the mutant. We have shown that serine 109
is a phosphoacceptor in vivo. The sequences sur- There may be regions, including serine 109, that are not
required for DNA binding, but play a role in modulatingrounding serine 109 suggest that either PKA and/or PKC
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Boyle, W. J., Van Der Geer, P., and Hunter, T. (1991). Phosphopeptidethis activity. Alternatively, the affect on DNA binding could
mapping and phosphoamino acid analysis by two-dimensional sepa-be indirect. E1 may bind inefficiently to the origin as a
ration on thin-layer cellulose plates. Methods Enzymol. 201, 110–
monomer, but require additional E1 molecules to form a 149.
functional complex at the origin. E1–E1 interactions Chen, E. Y., Howley, P. M., and Levinson, A. D. (1982). The primary
would therefore play an important role in determining the structure and genetic organization of the bovine papillomavirus type
1 genome. Nature 299, 529–534.efficiency of origin binding. It is unclear what comprises
Chiang, C.-M., Broker, T. R., and Chow, L. T. (1992a). Properties of bo-a functional E1 complex at the origin. Further work will
vine papillomavirus E1 mutants. Virology 191, 964–967.be required to determine the higher-order structure of a
Chiang, C.-M., Ustav, M., Stenlund, A., Ho, T. F., Broker, T. R., and Chow,
functional origin complex and the regions of the protein L. T. (1992b). Viral E1 and E2 proteins support replication of homolo-
that mediate putative E1–E1 interactions. gous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci.,
USA 89, 5799–5803.Binding efficiency could also explain our observations
Deng, W. P., and Nickoloff, J. A. (1992). Site-directed mutagenesis ofin light of the weak expression of E1 from the BPV ge-
virtually any plasmid by eliminating a unique site. Anal. Biochem.nome. Copy number or efficiency of replication may be
200, 81–88.
limited directly by the amount of E1 able to bind to the Dlugosz, A. A., and Yuspa, S. H. (1993). Coordinate changes in gene
replication origin. In our mutant, the amount of E1 is likely expression which mark the spinous to granular cell transition in
to be similar to that of wild-type. We have not altered epidermis are regulated by protein kinase C. J. Cell Biol. 120, 217–
225.any promoter sequences, and our results indirectly dem-
Fanning, E. (1992). Simian virus 40 large T antigen: The puzzle, theonstrate that protein stability has not been dramatically
pieces, and the emerging picture. J. Virol. 66, 1289–1293.changed. If origin binding efficiency by some mechanism
Gilbert, D., and Cohen, S. (1987). Bovine papillomavirus plasmids repli-
is enhanced, however, it may be possible to bind and cate randomly in mouse fibroblasts throughout S phase of the cell
replicate a higher number of viral genomes during each cycle. Cell 50, 59–68.
Gillette, T. G., Lusky, M., and Borowiec, J. A. (1994). Induction of struc-S phase.
tural changes in the bovine papillomavirus type 1 origin of replicationWe do not know which kinase(s) is responsible for
by the viral E1 and E2 proteins. Proc. Natl. Acad. Sci. USA 91, 8846–adding phosphate to serine 109 in vivo. It is interesting
8850.
to consider PKC as a possible kinase for this activity. Glaichenhaus, N., and Cuzin, F. (1987). A role for ID repetitive sequence
Serine 109 is in a favorable context for recognition by in growth- and transformation-dependent regulation of gene expres-
PKC, and, as we have shown here, will target serine 109 sion in rat fibroblasts. Cell 50, 1081–1090.
Harlow, E., and Lane, D. (1988). ‘‘Antibodies: A Laboratory Manual.’’and other positions on E1 in vitro. It has been clearly
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.shown that the PKC pathway is responsible for driving
Hirt, B. (1967). Selective extraction of polyoma DNA from infectedthe differentiation of keratinocytes, the natural host cell
mouse cell cultures. J. Mol. Biol. 26, 365–369.
for papillomaviruses (Dlugosz and Yuspa, 1993). Our re- Holt, S. E., Schuller, G., and Wilson, V. G. (1994). DNA binding specificity
sults suggest a possible connection between host cell of the bovine papillomavirus E1 protein is determined by sequences
contained within an 18-base-pair inverted repeat element at the ori-differentiation and viral DNA replication. It will be inter-
gin of replication. J. Virol. 68, 1094–1102.esting to examine the effect of inhibitors or stimulators
Holt, S. E., and Wilson, V. G. (1995). Mutational analysis of the 18-base-of PKC on viral DNA replication in vivo.
pair inverted repeat element at the bovine papillomavirus origin ofThis is the first example of a direct role for phosphory- replication: Identification of critical sequences for E1 binding and in
lation of the major viral replication protein, E1, in regulat- vivo replication. J. Virol. 69, 6525–6532.
ing BPV DNA replication. It is likely that phosphorylation Ho¨ss, A., Moarefi, I., Scheidtmann, K.-H., Cisek, L. J., Corden, J. L., Dorn-
reiter, I., Arthur, A. K., and Fanning, E. (1990). Altered phosphorylationof other sites on the E1 protein will be involved in modu-
pattern of simian virus 40 T antigen expressed in insect cells bylating viral DNA replication.
using a baculovirus vector. J. Virol. 64, 4799–4807.
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